NCT04604704: A trial that was reported late by AgelessRx
This trial has reported, although it was 435 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04604704 |
|---|---|
| Title | Pilot Study Into Low Dose Naltrexone (LDN) and Nicotinamide Adenine Dinucleotide (NAD+) for Treatment of Patients With Post-COVID-19 Syndrome (Long-COVID19) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 28, 2021 |
| Completion date | Jan. 23, 2023 |
| Required reporting date | Jan. 23, 2024, midnight |
| Actual reporting date | April 2, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 435 |